Cargando…
Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807331/ https://www.ncbi.nlm.nih.gov/pubmed/36605686 http://dx.doi.org/10.1002/iju5.12557 |
| _version_ | 1784862698531454976 |
|---|---|
| author | Hatano, Koji |
| author_facet | Hatano, Koji |
| author_sort | Hatano, Koji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9807331 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98073312023-01-04 Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” Hatano, Koji IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2022-11-08 /pmc/articles/PMC9807331/ /pubmed/36605686 http://dx.doi.org/10.1002/iju5.12557 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Comment Hatano, Koji Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” |
| title | Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” |
| title_full | Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” |
| title_fullStr | Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” |
| title_full_unstemmed | Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” |
| title_short | Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin” |
| title_sort | editorial comment on “two cases of crpc with brca mutation treated by olaparib after favorable response to cisplatin” |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807331/ https://www.ncbi.nlm.nih.gov/pubmed/36605686 http://dx.doi.org/10.1002/iju5.12557 |
| work_keys_str_mv | AT hatanokoji editorialcommentontwocasesofcrpcwithbrcamutationtreatedbyolaparibafterfavorableresponsetocisplatin |